|
Anesthetic
and Life Support Drugs Advisory Committee
Executive Secretary: Vicky Ferretti-Aceto, Pharm.D.,
R.Ph. (HFD-21), (301) 827-7001
November 10, 2005
- Notice of Meeting (pdf)
(htm)
- November 10, 2005 Final Agenda (pdf)
- November 10, 2005 Committee Roster (pdf)
- November 10, 2005 Transcript (pdf)
- November 10, 2005 Errata (pdf)
- November 10, 2005 Concordance Index (pdf)
Anti-Infective
Drugs Advisory Committee
Executive Secretary: LT Sohail Mosaddegh, Pharm.D.,
R.Ph., (HFD-21), (301) 827-7001
[Top]
Antiviral
Drugs Advisory Committee
Executive Secretary: Cicely Reese, Pharm.D.,
(HFD-21), (301) 827-7001
May 19, 2005
-
- May 19, 2005 Briefing
Information
- May 19, 2005 Final
Agenda (pdf)
(Word)
- May 19, 2005 Draft
Agenda (pdf)
(Word)
- May 19, 2005
Committee Roster (pdf)
(Word)
- May
19, 2005 Consultants/Guests Roster (pdf)
(Word)
- May 19, 2005 Final
Questions (pdf)
(Word)
- May 19, 2005
Slides
- May 19, 2005 Summary Minutes
(pdf) (Word)
- May 19, 2005 Transcript
Pages 1-100 (pdf) Pages
101-200 (pdf) Pages
201-300 (pdf) Pages
301-406 (pdf)
- May 19, 2005
Errata (pdf)
- May 19, 2005
Concordance Index (pdf)
[Top]
Arthritis
Drug Advisory Committee
Executive Secretary: Johanna Clifford, MS, RN,
BSN (HFD-21), (301) 827-7001
September 6, 2005
February 16-18, 2005 Joint Meeting with the Drug Safety
and Risk Management Advisory Committee
-
- February 16-18, 2005
Final Agenda (PDF)
(Word)
- February
16-18, 2005 Arthritis Committee Roster (PDF)
(Word)
- February
16-18, 2005 DSaRM Committee Roster (PDF)
(Word)
- February
16-18, 2005 Consultants/Guests Roster (PDF)
(Word)
- February 16-18,
2005 Discussion Points (PDF)
(Word)
- February 16-18, 2005 Briefing
Information
- February
16-18, 2005 Addendum to the FDA Briefing Information (PDF)
(Word)
- February 16, 2005 Slides
- February 16, 2005
Transcript (PDF)
(Word)
- February 16,
2005 Concordance Index (PDF)
- February 17, 2005 Slides
- February 17, 2005 Transcript
(PDF) (Word)
- February 17,
2005 Concordance Index (PDF)
- February 18, 2005 Slides
- February 18, 2005
Transcript (PDF)
(Word)
- February 18,
2005 Concordance Index (PDF)
- February 16-18, 2005
Summary Minutes (PDF)
(Word)
[Top]
Cardiovascular
& Renal Drugs Advisory Committee
Executive Secretary: Cathy Groupe, RN, BSN,
(HFD-21), (301) 827-7001
November 16, 2005
-
- June 15, 2005 Final
Agenda (PDF)
(Word)
- June 15-16,
2005 Committee Roster (PDF)
- June
15, 2005 Consultants/Guests Roster (PDF)
- June 15, 2005 Final
Questions (PDF)
- June
15, 2005 Briefing Information
- June 15, 2005 Slides
- June 15, 2005 Transcript
(PDF)
- June 15, 2005
Concordance Index (PDF)
- June 15, 2005 Summary Minutes
(PDF)
- June
16, 2005 Consultants/Guests Roster (PDF)
- June 16, 2005 Final
Questions (PDF)
- June
16, 2005 Briefing Information
- June 16, 2005 Slides
- June 15-16,
2005 Open Public Hearing Statements
- June 16, 2005 Transcript
(PDF)
- June 16, 2005
Concordance Index (PDF)
- June 16, 2005 Summary Minutes
(PDF)
[Top]
Dermatologic
and Ophthalmic Drugs Advisory Committee
Executive Secretary: LT Sohail Mosaddegh, Pharm.D.,
R.Ph., (HFD-21), (301) 827-7001
March 24, 2005 Joint Meeting with the Nonprescription
Drugs Advisory Committee
[Top]
Drug
Safety and Risk Management Advisory Committee
Executive Secretary: Vicky Ferretti-Aceto, PharmD,
RPh (HFD-21), (301) 827-7001
May 18-19, 2005
-
- Amendment
of Notice (PDF)
- May 18-19, 2005 Final
Agenda (PDF)
(Word)
- May 18-19,
2005 Committee Roster (PDF)
(Word)
- May
18-19, 2005 Participants Roster (PDF)
(Word)
- May
18-19, 2005 Briefing Information
- May 18, 2005 Questions
(PDF) (Word)
- May 18,
2005 Slides
- May 18, 2005 Transcript
(PDF)
- May 18, 2005
Concordance Index (PDF)
- May 19, 2005 Questions
(PDF) (Word)
- May 19,
2005 Slides
- May 19, 2005 Transcript
(PDF)
- May 19, 2005
Concordance Index (PDF)
February 16-18, 2005 Joint Meeting with the Arthritis
Drug Advisory Committee
-
- February 16-18, 2005
Final Agenda (PDF)
(Word)
- February
16-18, 2005 Arthritis Committee Roster (PDF)
(Word)
- February
16-18, 2005 DSaRM Committee Roster (PDF)
(Word)
- February
16-18, 2005 Consultants/Guests Roster (PDF)
(Word)
- February 16-18,
2005 Discussion Points (PDF)
(Word)
- February 16-18, 2005 Briefing
Information
- February
16-18, 2005 Addendum to the FDA Briefing Information (PDF)
(Word)
- February 16, 2005 Slides
- February 16, 2005 Transcript
(PDF) (Word)
- February 16,
2005 Concordance Index (PDF)
- February 17, 2005 Slides
- February 17, 2005 Transcript
(PDF) (Word)
- February 17,
2005 Concordance Index (PDF)
- February 18, 2005 Slides
- February 18, 2005 Transcript
(PDF) (Word)
- February 18,
2005 Concordance Index (PDF)
- February 16-18, 2005
Summary Minutes (PDF)
(Word)
[Top]
Endocrinologic
and Metabolic Drugs Advisory Committee
Executive Secretary: Cathy Groupe, RN, BSN, (HFD-21),
(301) 827-7001
September 8-9, 2005
- Notice
of Meeting (PDF)
- September 8, 2005
Final Agenda (PDF)
- Setember 8-9,
2005 Committee Roster (PDF)
- September
8, 2005 Consultants/Guests Roster (PDF)
- September 8, Final
Questions (PDF)
- September
8, 2005 Briefing Information
- September
8, 2005 Slides
- September 8, 2005 Summary
Minutes (PDF)
- September 8, 2005 Transcript
(PDF)
- September Concordance
Index (PDF)
- September 9, 2005
Final Agenda (PDF)
- September
9, 2005 Consultants/Guests Roster (PDF)
- September 9, Final
Questions (PDF)
- September
9, 2005 Briefing Information
- September
9, 2005 Slides
- September 9, 2005 Summary
Minutes (PDF)
- September 9, 2005 Transcript
(PDF)
- September 9,
2005 Concordance Index (PDF)
January 13-14, 2005 Joint meeting with the Nonprescription
Drugs Advisory Committee
- Notice
of Meeting (PDF)
- January 13-14, 2005
Final Agenda (PDF)
- January 13-14, 2005 Briefing
Information
- January 13-14, 2005 Questions [htm]
[pdf]
[ppt]
- January 13-14, 2005 Committee Roster (PDF)
- January 13-14, 2005 Consultants/Guests Roster (PDF)
- January 13, 2005 Slides
- January 13, 2005 Transcript
(PDF) (Word)
- January 13, 2005 Concordance Index (PDF)
- January 14, 2005 Slides
- January 14, 2005 Transcript
(PDF) (Word)
- January 14, 2005 Concordance Index (PDF)
- January 13-14, 2005 Summary
Minutes (PDF) (Word)
[Top]
Nonprescription
Drugs Advisory Committee
Executive Secretary: LT Darrell Lyons, BSN, RN,
(HFD-21), (301) 827-7001
October 20-21, 2005
March 24, 2005 Joint Meeting with the Dermatologic &
Ophthalmic Drugs Advisory Committee
- Notice
of Meeting (PDF)
- March 24, 2005 Final
Agenda (PDF)
- March
24, 2005 NDAC Committee Roster (PDF)
- March
24, 2005 DODAC Committee Roster (PDF)
- March
24, 2005 Consultants/Guests Roster (PDF)
- March
24, 2005 Briefing Information (PDF)
(Word)
- March 24, 2005 Slides
(Word)
-
- March
24, 2005 Briefing Information (PDF)
(Word)
- March 24, 2005 Slides
(Word)
- March 24, 2005
Errata to the Transcript (PDF)
(Word)
- March 24, 2005 Transcript
(PDF) (Word)
- March 24, 2005 Concordance Index (PDF)
March 23, 2005
January 13-14, 2005 Joint meeting with the Endocrinologic
and Metabolic Drugs Advisory Committee
- Notice
of Meeting (PDF)
- January 13-14, 2005
Final Agenda (PDF)
- January 13-14, 2005 Briefing
Information
- January 13-14, 2005 Questions [htm]
[pdf]
[ppt]
- January 13-14, 2005 Committee Roster (PDF)
- January 13-14, 2005 Consultants/Guests Roster (PDF)
- January 13, 2005 Slides
- January 13, 2005 Transcript
(PDF) (Word)
- January 13, 2005 Concordance Index (PDF)
- January 14, 2005 Slides
- January 14, 2005 Transcript
(PDF) (Word)
- January 14, 2005 Concordance Index (PDF)
- January 13-14, 2005 Summary
Minutes (PDF) (Word)
[Top]
Oncologic
Drugs Advisory Committee
Executive Secretary: Johanna M. Clifford, MS,
RN, (HFD-21), (301) 827-7001
November 8, 2005
October 20, 2005 Pediatric Oncology Subcommittee
September 13-14, 2005
- Notice
of Meeting (PDF)
- September 13, 2005
Final Agenda (PDF)
- September 13,
2005 Committee Roster (PDF)
- September
13, 2005 Consultants/Guests Roster (PDF)
- September
13, 2005 Briefing Information
- September 13,
2005 Slides
- September 13,
2005 Questions - Xinlay (PDF)
- September
13, 2005 Questions - Tarveva (PDF)
- September 13,
2005 Transcript Pages 1-100 (PDF) Pages
101-200 (PDF) Pages
201-300 (PDF) Pages
300-368 (PDF)
- September 13,
2005 Concordance Index (PDF)
- September
14, 2005 Briefing Information
- September
14, 2005 Questions - Revlimid (PDF)
- September
14, 2005 Questions - Arranon (PDF)
- September 14,
2005 Transcript Pages 1-100 (PDF) Pages
101-200 (PDF) Pages
201-300 (PDF) Pages
301-356 (PDF)
- September 14,
2005 Concordance Index (PDF)
- September 14,
2005 Slides
May 5, 2005
March 3-4, 2005
- Notice
of Meeting (PDF)
- March 3, 3005 Final
Agenda (PDF)
- March 3, 2005
Committee Roster (PDF)
- March
3, 2005 Consultants/Guests Roster (PDF)
- March
3, 2005 Combidex Questions (PDF)
- March
3, 2005 Iressa Questions (PDF)
- March 3, 2005 Briefing
Information
- March 3, 2005 Slides
(PDF) (Word)
- March 3, 2005 Transcript
(PDF) (Word)
- March 3, 2005
Concordance Index (PDF)
- March
4, 2005 Prostate Cancer Endpoint Questions (PDF)
- March
4, 2005 Zometa-Aredia Questions (PDF)
- March 4, 2005 Briefing
Information
- March 4, 2005 Slides
(PDF) (Word)
- March 4, 2005 Transcript
(PDF) (Word)
- March 4, 2005
Concordance Index (PDF)
[Top]
Peripheral
and Central Nervous System Drugs Advisory Committee
Executive Secretary: LT Darrell Lyons, BSN, RN,
(HFD-21), 301 827-7001
August 4, 2005
- Notice
of Meeting (PDF)
- August 4, 2005 Final
Agenda (PDF)
- August 4, 2005
Committee Roster (PDF)
- August
4, 2005 Consultants/Guests Roster (PDF)
- August 4, 2005
Questions (PDF)
- August
4, 2005 Briefing Information
- August 4, 2005
Slides
- August 4, 2005 Transcript
(PDF) (Word)
- August 4, 2005
Concordance Index (PDF)
- August 4, 2005
Errata (PDF)
- August 4, 2005 Summary
Minutes (PDF) (Word)
Pharmaceutical
Science Advisory Committee
Executive Secretary: Mimi Phan, Pharm.D., (HFD-21),
(301) 827-7001
November 14-15, 2005 Clinical Pharmacology Subcommittee
October 25-26, 2005
May 3-4, 2005
[Top]
Psychopharmacologic
Drugs Advisory Committee
Executive Secretary: Cicely Reese, Pharm.D., (HFD-21),
(301) 827-7001
December 2, 2005
October 25-26, 2005
- Notice
of Meeting (PDF)
- October 25,
2005 Briefing Information
- October
25, 2005 Slides
- October 25, 2005 Transcript
(PDF)
- October 25, 2005
Concordance Index (PDF)
- October
26, 2005 Briefing Information
- October
26, 2005 Slides
- October 26, 2005 Transcript
(PDF)
- October 26, 2005
Erratta (PDF)
- October 26, 2005
Concordance Index (PDF)
- October 25-26, 2005 Summary
Minutes (PDF)
[Top]
Pulmonary-Allergy
Drugs Advisory Committee
Executive Secretary: Teresa Watkins, R.Ph., (HFD-21),
(301) 827-7001
July 13-14, 2005
June 6, 2005
[Top]
Page updated:
September 18, 2007
|
|